Cargando…

Splice modulating oligomers as cancer therapeutics

Detalles Bibliográficos
Autores principales:	Chen, KuanHui E., Walker, Ameae M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2022
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9423660/ https://www.ncbi.nlm.nih.gov/pubmed/36051750 http://dx.doi.org/10.18632/genesandcancer.222

Ejemplares similares

Sex Differences in Mouse Popliteal Lymph Nodes
por: Dill-Garlow, Riva, et al.
Publicado: (2019)

Enzyme-linked oligonucleotide hybridization assay for direct oligo measurement in blood
por: Lorenson, Mary Y, et al.
Publicado: (2019)

Involvement of miR-106b in tumorigenic actions of both prolactin and estradiol
por: Chen, Kuan-Hui Ethan, et al.
Publicado: (2017)

Abnormal protein oligomers for neurodegeneration
por: Tokuda, Eiichi, et al.
Publicado: (2017)

Tumor cell-derived asymmetric dimethylarginine regulates macrophage functions and polarization
por: Chen, Yi-Ling, et al.
Publicado: (2022)

Aβ oligomers: role at the synapse
por: Puzzo, Daniela
Publicado: (2019)

Reversibility of Aβ oligomer neurotoxicity
por: Araki, Wataru
Publicado: (2017)

Morpholino Antisense Oligomers as a Potential Therapeutic Option for the Correction of Alternative Splicing in PMD, SPG2, and HEMS
por: Tantzer, Stephanie, et al.
Publicado: (2018)

Sensitivity to splicing modulation of BCL2 family genes defines cancer therapeutic strategies for splicing modulators
por: Aird, Daniel, et al.
Publicado: (2019)

Therapeutic targeting of alternative splicing to inhibit hepatocellular carcinoma metastasis
por: Lee, Yun-Han
Publicado: (2022)

Alternative Splicing and Cancer
por: Auboeuf, Didier, et al.
Publicado: (2012)

Trapping the oligomers: new promises in neurosciences
por: Imberdis, Thibaut, et al.
Publicado: (2016)

Use of a novel camelid-inspired human antibody demonstrates the importance of MMP-14 to cancer stem cell function in the metastatic process
por: Chen, Kuan-Hui E., et al.
Publicado: (2018)

Synthesis, Processing and Applications of Conjugated Oligomers and Polymers 2.0
por: Pasini, Dario, et al.
Publicado: (2023)

Prolactin enhances T regulatory cell promotion of breast cancer through the long form prolactin receptor
por: Chen, Kuan-Hui Ethan, et al.
Publicado: (2021)

S179D Prolactin Sensitizes Human PC3 Prostate Cancer Xenografts to Anti-tumor Effects of Well-Tolerated Doses of Calcitriol
por: Holland, Christopher T., et al.
Publicado: (2020)

Electroporation Enhanced Effect of Dystrophin Splice Switching PNA Oligomers in Normal and Dystrophic Muscle
por: Brolin, Camilla, et al.
Publicado: (2015)

RNA Splicing in Cancer and Targeted Therapies
por: Islam, Md Rafikul, et al.
Publicado: (2023)

Aberrant Bcl-x splicing in cancer: from molecular mechanism to therapeutic modulation
por: Dou, Zhihui, et al.
Publicado: (2021)

Therapeutic Strategies to Reduce the Toxicity of Misfolded Protein Oligomers
por: Kreiser, Ryan P., et al.
Publicado: (2020)

Bittersweet: relevant amounts of the common sweet food additive, glycerol, accelerate the growth of PC3 human prostate cancer xenografts
por: DeGuzman, Ariel, et al.
Publicado: (2022)

Alternative Splicing: Role in Cancer Development and Progression
por: Sette, Claudio, et al.
Publicado: (2013)

Trans-Epithelial Immune Cell Transfer during Suckling Modulates Delayed-Type Hypersensitivity in Recipients as a Function of Gender
por: Ma, Lisa J., et al.
Publicado: (2008)

Modulation of splicing catalysis for therapeutic targeting of leukemias with spliceosomal mutations
por: Lee, Stanley Chun-Wei, et al.
Publicado: (2016)

Toxic Tau Oligomers Modulated by Novel Curcumin Derivatives
por: Lo Cascio, Filippa, et al.
Publicado: (2019)

Blocking the 5′ splice site of exon 4 by a morpholino oligomer triggers APOL1 protein isoform switch
por: Cheatham, Amber M., et al.
Publicado: (2018)

Role of androgen receptor splice variants in prostate cancer metastasis
por: Xu, Jin, et al.
Publicado: (2016)

HCS-Splice: A High-Content Screening Method to Advance the Discovery of RNA Splicing-Modulating Therapeutics
por: Covello, Giuseppina, et al.
Publicado: (2023)

Aberrant Cyclin D1 splicing in cancer: from molecular mechanism to therapeutic modulation
por: Wang, Jing, et al.
Publicado: (2023)

Molecular Threat of Splicing Factor Mutations to Myeloid Malignancies and Potential Therapeutic Modulations
por: Zhang, Fangliang, et al.
Publicado: (2022)

Regulation of RNA Splicing: Aberrant Splicing Regulation and Therapeutic Targets in Cancer
por: Kitamura, Koji, et al.
Publicado: (2021)

Therapeutic Targeting of RNA Splicing in Cancer
por: Bonner, Elizabeth A., et al.
Publicado: (2023)

Reconstitution of Pure Chaperonin Hetero-Oligomer Preparations in Vitro by Temperature Modulation
por: Vitlin Gruber, Anna, et al.
Publicado: (2018)

Prolactin Receptor (PRLR) Isoform Expression in the Murine Oviduct
por: Radecki, Kelly C, et al.
Publicado: (2021)

Modulation of nuclear REST by alternative splicing: a potential therapeutic target for Huntington's disease
por: Chen, Guo‐Lin, et al.
Publicado: (2017)

Modulation of Toll-Like Receptor Signalling as a New Therapeutic Principle
por: Lepper, Philipp M., et al.
Publicado: (2010)

Alternative Splicing in Human Physiology and Disease
por: Artemaki, Pinelopi I., et al.
Publicado: (2022)

Targeting splicing factors as molecular non-muscle invasive bladder cancer predictors
por: Lee, Kyoung-Hwa, et al.
Publicado: (2018)

Are cis-spliced fusion proteins pathological in more aggressive luminal breast cancer?
por: Liu, Chia-Chia, et al.
Publicado: (2023)

Resveratrol Oligomers for the Prevention and Treatment of Cancers
por: Xue, You-Qiu, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_qaak3hl5etbnitdm8b08mb0m9t